QT prolongation with anticancer drugs: a multimodal issue
- PMID: 36455571
- DOI: 10.1016/S1470-2045(22)00622-2
QT prolongation with anticancer drugs: a multimodal issue
Conflict of interest statement
We declare no competing interests.
Comment in
-
QT prolongation with anticancer drugs: a multimodal issue - Authors' reply.Lancet Oncol. 2022 Dec;23(12):e523. doi: 10.1016/S1470-2045(22)00695-7. Lancet Oncol. 2022. PMID: 36455572 No abstract available.
Comment on
-
The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overview.Lancet Oncol. 2022 Sep;23(9):e406-e415. doi: 10.1016/S1470-2045(22)00221-2. Lancet Oncol. 2022. PMID: 36055309 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources